Proportion of treatment effect for primary composite outcome explained by 2
month biomarkers
diabetes
EVENT, DIABETES
Analyses restricted to 5465 participants with measurements of uACR,
SBP, DBP and HbA1c at 2 months. Participants experiencing an event in the
first two months of follow-up were excluded.After adjustment for biomarkers at 2 months. All analyses
additionally adjusted for baseline variables specified in the minimisation
algorithm (age, sex, prior diabetes, eGFR, uACR and region).